Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

Anna P. Durbin, Maria Vargas, Kimberli Wanionek, +5

Virology

Increased ActivationHumoral ResponseHematologyImmunologyBlood Cell +6

A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial

Anna P. Durbin, Beth D. Kirkpatrick, Kristen K. Pierce, +14

The Journal of Infectious Diseases

rDEN2/4Δ30(ME), a Live Attenuated Chimeric Dengue Serotype 2 Vaccine, is Safe and Highly Immunogenic in Healthy Dengue-Naïve Adults

Anna P. Durbin, Julie H. McArthur, Jennifer A. Marron, +4

Human Vaccines

VaccinationVaccine DevelopmentHighly ImmunogenicVaccine TargetImmunology +11

Live-attenuated Vaccines Prevent Respiratory Syncytial Virus–associated Illness in Young Children

Ruth A. Karron, Jessica E. Atwell, Elizabeth J. McFarland, +11

American Journal of Respiratory and Critical Care Medicine

Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children

Ruth A. Karron, Cindy Luongo, Jocelyn San Mateo, +3

The Journal of Infectious Diseases

The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers

Anna P. Durbin, Peter F. Wright, Amber Bickford Cox, +7

Vaccine

VaccinationVaccine DevelopmentImmunologyVirologyVaccine Design +3

Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children

Ruth A. Karron, Jocelyn San Mateo, Kimberli Wanionek, +2

Journal of the Pediatric Infectious Diseases Society

VaccinationVaccine SafetyVaccine DevelopmentHmpv-seronegative ChildrenVaccine Target +4

Heterotypic Dengue Infection with Live Attenuated Monotypic Dengue Virus Vaccines: Implications for Vaccination of Populations in Areas Where Dengue Is Endemic

Anna P. Durbin, Alexander Schmidt, Dan Elwood, +5

The Journal of Infectious Diseases

A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial

Anna P. Durbin, Stephen S. Whitehead, Donna Shaffer, +6

PLoS neglected tropical diseases

Dengue VirusImmunologyArbovirusCandidate VaccineVaccine Target +15

Evaluation of the Live-Attenuated Intranasal Respiratory Syncytial Virus (RSV) Vaccine RSV/6120/ΔNS2/1030s in RSV-Seronegative Young Children

Ruth A. Karron, Cindy Luongo, Suzanne Woods, +16

The Journal of Infectious Diseases